Sponsored by Cory A. Booker (D)
FDA Modernization Act 3.0
Would have required FDA to replace animal-testing references with nonclinical-testing references in its drug rules.
Tradeoff
Would have let drug makers use nonclinical testing methods, including alternatives to animal tests, in drug-trial applications. The FDA would have needed to publish the rule within one year.
What's in it
The Senate passed this by on December 12, 2024. The House never voted on it before the Congress ended, so the bill expired.
Senate
Introduced
(Sep 12, 2024)
Senate
Committee on Health, Education, Labor, and Pensions(Sep 12, 2024)
Senate · Amended
Senator Booker's
Agreed to by (S.Amdt. 3328 · Dec 12, 2024)
Replaces a final rule on nonclinical testing with an interim final rule that takes effect immediately and swaps animal test references for nonclinical ones in drug regulations.
No individual votes were recorded.
Senate
Passage of the bill
Passed by (Dec 12, 2024)
No individual votes were recorded.
Senate
Taken away from the Committee on Health, Education, Labor, and Pensions
Discharged(Dec 12, 2024)
House
Received from the Senate
Received(Dec 16, 2024)
- Eric Schmitt (R-MO)
- Rand Paul (R-KY)
- Angus S., Jr. King (I-ME)
- Mike Braun (R-IN)
- Sheldon Whitehouse (D-RI)
- John Kennedy (R-LA)
- Ben Ray Luján (D-NM)
- Richard Blumenthal (D-CT)
- Roger Marshall (R-KS)